Computerized Registry of Patients With Venous Thromboembolism (RIETE) (NCT02832245)
🩺 Plain-English Summary (8th-Grade Level)
The Computerized Registry of Patients with Venous Thromboembolism (RIETE) is a multidisciplinary Project initiated in march 2001 and consisting in obtaining an extensive data registry of consecutive patients with venous thromboembolism. The main objective is to provide information on the Internet to help physicians to improve their knowledge on the natural history of thromboembolic disease, particularly in those subgroups of patients who are usually not recruited in randomized clinical trials (pregnant women, elderly patients, disseminated cancer, severe renal insufficiency, patients with contraindications to anticoagulation therapy, extreme body weight, etc), with the purpose of decreasing mortality, frequency of thromboembolic recurrences as well as bleeding complications and arterial events. As an additional objective RIETE is also aimed to create predictive scores that help physicians to better identify patients with high risk of presenting some of these complications. The primary parameters recorded by the registry comprise details of each patient's clinical status, including any coexisting or underlying conditions, and the type, dose, duration and outcome (during the first 3 months of therapy) of antithrombotic treatment. Study endpoints are clinically recognized (and objectively confirmed) recurrences of VTE, major and minor bleeding complications, and death.
Who can join: Review the eligibility criteria below.
Location: Yale University School of Medicine — New Haven, Connecticut
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (257 Sites)
Showing the first 25 of 257 sites.
- Yale University School of Medicine — New Haven, Connecticut
- College of Medicine - Jacksonville University of Florida — Jacksonville, Florida
- Evanston NorthShore University HealthSystem — Evanston, Illinois
- Massachusetts General Hospital — Boston, Massachusetts
- Northwell Health System — Manhasset, New York
- Medical College of Wisconsin — Milwaukee, Wisconsin
- Clínica San Camilo — Buenos Aires, Buenos Aires
- Hospital Italiano de Buenos Aires — Buenos Aires, Buenos Aires
- Clínica Privada Pueyrredón — Mar del Plata, Buenos Aires
- Medical University of Vienna — Vienna, State of Vienna
- Hospital UZ Leuven — Leuven, Leuven
- Hospital Jorge Valente — Salvador, Estado de Bahia
- Hospital Glória d'Or — Rio de Janeiro, Rio de Janeiro
- Hospital Cardio Pulmonar — Salvador, Salvador
- Botucatu Medical School - São Paulo State University (UNESP) — Botucatu, São Paulo
- The Seven Medical Center of Chinese PLA General Hospital — Beijing, Beijing Municipality
- Peking University Cancer Hospital and Institute — Beijing, Beijing Municipality
- Hospital Universitario San Vicente Fundación — Medellín, Antioquia
- Hospital Universitario Fundación Santa Fé de Bogota — Bogotá, Bogota D.C.
- Hospital Universitario Fundación Valle del Lili — Cali, Colombia
- Hospital Universitario San José de Buga Fundación — Guadalajara de Buga, Valle del Cauca Department
- University Hospital Hradec Kralove — Hradec Králové, Hradec Králové
- Hospital Pardubická Krasjská Nemocnice A.S. — Pardubice, Pardubice
- University Hospital Plzen — Pilsen, Plzen
- Hospital Luis Vernaza — Guayaquil, Guayas
📞 Contact the Study Coordinator
Phone: 0034915357183
Email: riete@shmedical.es
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Venous Thromboembolism
- Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery — Charleston, South Carolina
- Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism — Basking Ridge, New Jersey
- Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty — Miami, Florida
- Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters — Halifax, Nova Scotia
- DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis — Scottsdale, Arizona
- Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis — Ottawa, Ontario
Explore by condition: All Venous Thromboembolism clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.